Man Group plc reduced its stake in Seer, Inc. (NASDAQ:SEER - Free Report) by 91.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,288 shares of the company's stock after selling 185,509 shares during the quarter. Man Group plc's holdings in Seer were worth $38,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of SEER. Peapod Lane Capital LLC purchased a new position in Seer during the 4th quarter worth approximately $991,000. Renaissance Technologies LLC raised its position in Seer by 27.0% during the 4th quarter. Renaissance Technologies LLC now owns 843,700 shares of the company's stock worth $1,949,000 after buying an additional 179,568 shares during the last quarter. Bridgeway Capital Management LLC raised its position in Seer by 17.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 727,743 shares of the company's stock worth $1,681,000 after buying an additional 109,000 shares during the last quarter. D. E. Shaw & Co. Inc. raised its position in Seer by 16.8% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 719,901 shares of the company's stock worth $1,663,000 after buying an additional 103,630 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. purchased a new position in Seer during the 4th quarter worth approximately $179,000. 75.20% of the stock is owned by hedge funds and other institutional investors.
Seer Price Performance
SEER traded up $0.22 during trading on Monday, reaching $2.14. 386,792 shares of the company's stock were exchanged, compared to its average volume of 341,283. Seer, Inc. has a 1 year low of $1.56 and a 1 year high of $2.63. The stock has a market capitalization of $125.98 million, a P/E ratio of -1.65 and a beta of 1.58. The company's fifty day simple moving average is $1.95 and its 200-day simple moving average is $2.16.
Seer (NASDAQ:SEER - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.03. The company had revenue of $4.21 million during the quarter, compared to analyst estimates of $3.25 million. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. Equities analysts forecast that Seer, Inc. will post -1.42 EPS for the current year.
About Seer
(
Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Featured Articles
Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
